PLoS ONE (Jan 2021)

Correction: In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells.

  • Septelia Inawati Wanandi,
  • Agus Limanto,
  • Elvira Yunita,
  • Resda Akhra Syahrani,
  • Melva Louisa,
  • Agung Eru Wibowo,
  • Sekar Arumsari

DOI
https://doi.org/10.1371/journal.pone.0247694
Journal volume & issue
Vol. 16, no. 2
p. e0247694

Abstract

Read online

[This corrects the article DOI: 10.1371/journal.pone.0240020.].